Drug-induced agranulocytosis, with special reference to aminophenazone. IV. Children.
D000380:Agranulocytosis / Q000139:chemically induced* / Q000453:epidemiology / Q000401:mortality; D000632:Aminopyrine / Q000009:adverse effects* / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D002701:Chloramphenicol / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D005387:Finland; D006801:Humans; D007223:Infant; D008297:Male; D011398:Promethazine / Q000009:adverse effects / Q000627:therapeutic use; D012141:Respiratory Tract Infections / Q000188:drug therapy; D013443:Sulfisomidine / Q000009:adverse effects / Q000627:therapeutic use; D014552:Urinary Tract Infections / Q000188:drug therapy
D000632:Aminopyrine; D002701:Chloramphenicol; D011398:Promethazine; D013443:Sulfisomidine